Enalapril Maleate
- Product NDC
- 68071-3221
- 11-digit product format
- 680713221
- Labeler code
- 68071
- Product ID
- 68071-3221_5175a4c0-e71d-6701-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Enalapril Maleate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA075479
- Marketing category
- ANDA
- Marketing start
- 2000-08-23
- Marketing end
- 0000-00-00
- Substance
- ENALAPRIL MALEATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-3221-1 | 2020-05-07 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |
| 68071-3221-3 | 2020-05-07 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |
| 68071-3221-6 | 2020-05-07 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |
| 68071-3221-9 | 2020-05-07 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |
| 68071-3221-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |
| 68071-3221-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |
| 68071-3221-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |
| 68071-3221-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0f60-f424-e053-dadaa90a57ce | 51753d63-c10d-3692-e054-00144ff88e88 |